Radiotherapy Research Today is a free monthly online journal that collates and summarizes the latest research about Radiotherapy, including details on cancer treatment, side effects.

Volume 1 (2004), Issue 1 (August)

1. Synthesis of novel carboranylchlorins with dual application in boron neutron capture therapy (BNCT) and photodynamic therapy (PDT).
   Appl Radiat Isot, 61(5): 1117-23. [Abstract] [Full-text]
2. First BNCT treatment of a skin melanoma in Argentina: dosimetric analysis and clinical outcome.
   Appl Radiat Isot, 61(5): 1101-5. [Abstract] [Full-text]
3. Biodistribution studies of boronophenylalanine-fructose in melanoma and brain tumor patients in Argentina.
   Appl Radiat Isot, 61(5): 1095-100. [Abstract] [Full-text]
4. Current clinical results of the Tsukuba BNCT trial.
   Appl Radiat Isot, 61(5): 1089-93. [Abstract] [Full-text]
5. Tolerance of normal human brain to boron neutron capture therapy.
   Appl Radiat Isot, 61(5): 1083-7. [Abstract] [Full-text]
6. Preliminary treatment planning and dosimetry for a clinical trial of neutron capture therapy using a fission converter epithermal neutron beam.
   Appl Radiat Isot, 61(5): 1075-81. [Abstract] [Full-text]
7. Effectiveness of BNCT for recurrent head and neck malignancies.
   Appl Radiat Isot, 61(5): 1069-73. [Abstract] [Full-text]
8. Radiation injury of boron neutron capture therapy using mixed epithermal- and thermal neutron beams in patients with malignant glioma.
   Appl Radiat Isot, 61(5): 1063-7. [Abstract] [Full-text]
9. GE PETtrace cyclotron as a neutron source for boron neutron capture therapy.
   Appl Radiat Isot, 61(5): 1057-62. [Abstract] [Full-text]
10. Spatial characterization of BNCT beams.
    Appl Radiat Isot, 61(5): 1051-5. [Abstract] [Full-text]
11. Improvement of dose calculation accuracy for BNCT dosimetry by the multi-voxel method in JCDS.
    Appl Radiat Isot, 61(5): 1045-50. [Abstract] [Full-text]
12. Renovation of epithermal neutron beam for BNCT at THOR.
    Appl Radiat Isot, 61(5): 1039-43. [Abstract] [Full-text]
13. Implantable self-powered detector for on-line determination of neutron flux in patients during NCT treatment.
    Appl Radiat Isot, 61(5): 1033-7. [Abstract] [Full-text]
14. A shielding design for an accelerator-based neutron source for boron neutron capture therapy.
    Appl Radiat Isot, 61(5): 1027-31. [Abstract] [Full-text]
15. Measurement of free beam neutron spectra at eight BNCT facilities worldwide.
    Appl Radiat Isot, 61(5): 1021-6. [Abstract] [Full-text]
16. Quality assurance procedures for the neutron beam monitors at the FiR 1 BNCT facility.
    Appl Radiat Isot, 61(5): 1015-9. [Abstract] [Full-text]
17. Optimization of an accelerator-based epithermal neutron source for neutron capture therapy.
    Appl Radiat Isot, 61(5): 1009-13. [Abstract] [Full-text]
18. Optimization parameters for BDE in BNCT using near threshold 7Li(p,n)7Be direct neutrons.
    Appl Radiat Isot, 61(5): 1003-8. [Abstract] [Full-text]
19. Benchmark experiments for cyclotron-based neutron source for BNCT.
    Appl Radiat Isot, 61(5): 997-1001. [Abstract] [Full-text]
20. Flux and instrumentation upgrade for the epithermal neutron beam facility at Washington State University.
    Appl Radiat Isot, 61(5): 993-6. [Abstract] [Full-text]
21. An epithermal facility for treating brain gliomas at the TAPIRO reactor.
    Appl Radiat Isot, 61(5): 987-91. [Abstract] [Full-text]
22. Boronated epidermal growth factor as a delivery agent for neutron capture therapy of EGF receptor positive gliomas.
    Appl Radiat Isot, 61(5): 981-5. [Abstract] [Full-text]
23. Effects of boron neutron capture irradiation on the normal lung of rats.
    Appl Radiat Isot, 61(5): 969-73. [Abstract] [Full-text]
24. Targeting liposomes to tumor endothelial cells for neutron capture therapy.
    Appl Radiat Isot, 61(5): 963-7. [Abstract] [Full-text]
25. T cell uptake for the use of boron neutron capture as an immunologic research tool.
    Appl Radiat Isot, 61(5): 959-62. [Abstract] [Full-text]
26. The usefulness of 2-nitroimidazole-sodium borocaptate-10B conjugates as 10B-carriers in boron neutron capture therapy.
    Appl Radiat Isot, 61(5): 953-8. [Abstract] [Full-text]
27. BNCT of 3 cases of spontaneous head and neck cancer in feline patients.
    Appl Radiat Isot, 61(5): 947-52. [Abstract] [Full-text]
28. Radiobiology of BNCT mediated by GB-10 and GB-10+BPA in experimental oral cancer.
    Appl Radiat Isot, 61(5): 939-45. [Abstract] [Full-text]
29. Biodistribution of 10B in a rat liver tumor model following intra-arterial administration of sodium borocaptate (BSH)/degradable starch microspheres (DSM) emulsion.
    Appl Radiat Isot, 61(5): 933-7. [Abstract] [Full-text]
30. A new approach to determine tumor-to-blood 10B concentration ratios from the clinical outcome of a BNCT treatment.
    Appl Radiat Isot, 61(5): 923-8. [Abstract] [Full-text]
31. Biodistribution of p-borophenylalanine (BPA) in dogs with spontaneous undifferentiated thyroid carcinoma (UTC).
    Appl Radiat Isot, 61(5): 911-5. [Abstract] [Full-text]
32. Boron neutron capture therapy for undifferentiated thyroid carcinoma: preliminary results with the combined use of BPA and BOPP.
    Appl Radiat Isot, 61(5): 905-9. [Abstract] [Full-text]
33. Neutron capture therapy of epidermal growth factor (+) gliomas using boronated cetuximab (IMC-C225) as a delivery agent.
    Appl Radiat Isot, 61(5): 899-903. [Abstract] [Full-text]
34. Experimental and computational validation of BDTPS using a heterogeneous boron phantom.
    Appl Radiat Isot, 61(5): 893-7. [Abstract] [Full-text]
35. Dose-rate scaling factor estimation of THOR BNCT test beam.
    Appl Radiat Isot, 61(5): 881-5. [Abstract] [Full-text]
36. Characteristics of BDE dependent on 10B concentration for accelerator-based BNCT using near-threshold 7Li(p,n)7Be direct neutrons.
    Appl Radiat Isot, 61(5): 875-9. [Abstract] [Full-text]
37. Monte-Carlo calculations for the development of a BNCT neutron source at the Kyiv Research Reactor.
    Appl Radiat Isot, 61(5): 869-73. [Abstract] [Full-text]
38. Progress with the NCT international dosimetry exchange.
    Appl Radiat Isot, 61(5): 865-8. [Abstract] [Full-text]
39. Characteristics of the new THOR epithermal neutron beam for BNCT.
    Appl Radiat Isot, 61(5): 861-4. [Abstract] [Full-text]
40. BNCT dose distribution in liver with epithermal D-D and D-T fusion-based neutron beams.
    Appl Radiat Isot, 61(5): 853-9. [Abstract] [Full-text]
41. Development of equipments for determination of BNCT source spectral parameters.
    Appl Radiat Isot, 61(5): 849-52. [Abstract] [Full-text]
42. Dosimetric comparison at FiR 1 using microdosimetry, ionisation chambers and computer simulation.
    Appl Radiat Isot, 61(5): 845-8. [Abstract] [Full-text]
43. Neutron fibres and possible applications to NCT.
    Appl Radiat Isot, 61(5): 841-4. [Abstract] [Full-text]
44. BNCT dose calculation in irregular fields using the sector integration method.
    Appl Radiat Isot, 61(5): 835-40. [Abstract] [Full-text]
45. The irradiation system and dose estimation joint-system for NCT wider application in Kyoto University.
    Appl Radiat Isot, 61(5): 829-33. [Abstract] [Full-text]
46. Enhanced blood boron concentration estimation for BPA-F mediated BNCT.
    Appl Radiat Isot, 61(5): 823-7. [Abstract] [Full-text]
47. Lithium neutron producing target for BINP accelerator-based neutron source.
    Appl Radiat Isot, 61(5): 817-21. [Abstract] [Full-text]
48. An optimized neutron-beam shaping assembly for accelerator-based BNCT.
    Appl Radiat Isot, 61(5): 811-5. [Abstract] [Full-text]
49. Comparison of the performance of two NCT treatment planning systems using the therapeutic beam of the RA-6 reactor.
    Appl Radiat Isot, 61(5): 805-10. [Abstract] [Full-text]
50. Design and construction of shoulder recesses into the beam aperture shields for improved patient positioning at the FiR 1 BNCT facility.
    Appl Radiat Isot, 61(5): 799-803. [Abstract] [Full-text]
51. The TL analysis methods used to determine absorbed gamma doses in vivo for the BNCT patients treated at FiR 1.
    Appl Radiat Isot, 61(5): 793-7. [Abstract] [Full-text]
52. A dosimetric study on the use of bolus materials for treatment of superficial tumors with BNCT.
    Appl Radiat Isot, 61(5): 787-91. [Abstract] [Full-text]
53. MCNP study for epithermal neutron irradiation of an isolated liver at the Finnish BNCT facility.
    Appl Radiat Isot, 61(5): 781-5. [Abstract] [Full-text]
54. Development of real-time thermal neutron monitor using boron-loaded plastic scintillator with optical fiber for boron neutron capture therapy.
    Appl Radiat Isot, 61(5): 775-9. [Abstract] [Full-text]
55. Microdistributions of prospective BNCT-compound CuTCPH in tissue sections with a heavy ion microbeam.
    Appl Radiat Isot, 61(5): 771-4. [Abstract] [Full-text]
56. Development and application of an unconstrained technique for patient positioning in fixed radiation beams.
    Appl Radiat Isot, 61(5): 765-9. [Abstract] [Full-text]
57. In-phantom imaging of all dose components in boron neutron capture therapy by means of gel dosimeters.
    Appl Radiat Isot, 61(5): 759-63. [Abstract] [Full-text]
58. Moderated 252Cf neutron energy spectra in brain tissue and calculated boron neutron capture dose.
    Appl Radiat Isot, 61(5): 753-7. [Abstract] [Full-text]
59. MINERVA-a multi-modal radiation treatment planning system.
    Appl Radiat Isot, 61(5): 745-52. [Abstract] [Full-text]
60. Calculations of cellular microdosimetry parameters for alpha particles and electrons.
    Appl Radiat Isot, 61(5): 739-43. [Abstract] [Full-text]
61. In-phantom characterisation studies at the Birmingham Accelerator-Generated epIthermal Neutron Source (BAGINS) BNCT facility.
    Appl Radiat Isot, 61(5): 733-8. [Abstract] [Full-text]
62. Whole-body exposure to 2.45 GHz electromagnetic fields does not alter radial-maze performance in rats.
    Behav Brain Res, 155(1): 37-43. [Abstract] [Full-text]

© 2004-2008 Radiotherapy Research Today. All Rights Reserved.